|
diabetes |
19 |
|
osteoporosis |
19 |
|
epidemiology |
16 |
|
humans |
15 |
|
adult |
14 |
|
bone mineral density |
14 |
|
cohort studies |
14 |
|
female |
14 |
|
bone density |
13 |
|
mendelian randomization |
13 |
|
covid-19 vaccines |
12 |
|
innate immunity |
12 |
|
tuberculosis |
12 |
|
bmd |
11 |
|
chinese |
11 |
|
aged |
10 |
|
bone density - genetics |
10 |
|
cancer |
10 |
|
causality |
10 |
|
covid-19 |
10 |
|
middle aged |
10 |
|
polymorphism, single nucleotide |
10 |
|
algorithms |
9 |
|
animals |
9 |
|
association |
9 |
|
cardiovascular complications |
9 |
|
china |
9 |
|
fracture |
9 |
|
infection |
9 |
|
mice |
9 |
|
microvascular complications |
9 |
|
sars-cov-2 |
9 |
|
cardiovascular disease |
8 |
|
ehr |
8 |
|
electronic health record |
8 |
|
genetics |
8 |
|
male |
8 |
|
meta-analysis |
8 |
|
pharmacoepidemiology |
8 |
|
validation |
8 |
|
cer1 |
7 |
|
genetic correlation |
7 |
|
haplotypes |
7 |
|
lumbar disc degeneration |
7 |
|
mortality |
7 |
|
osteoarthritis |
7 |
|
pleiotropy |
7 |
|
polygenic score |
7 |
|
aged, 80 and over |
6 |
|
allele |
6 |
|
animal cell |
6 |
|
anti-coagulant |
6 |
|
antiresorptives |
6 |
|
asian continental ancestry group - genetics |
6 |
|
atrial fibrillation |
6 |
|
bone metabolism |
6 |
|
calcium |
6 |
|
case-control studies |
6 |
|
cell line |
6 |
|
cytokines - genetics |
6 |
|
disease and disorders of/related to bone |
6 |
|
dna-binding proteins - genetics - metabolism |
6 |
|
doac |
6 |
|
epidemiological studies |
6 |
|
fractures, bone - genetics |
6 |
|
general population studies |
6 |
|
genetic association |
6 |
|
genetic disease |
6 |
|
genome-wide association study |
6 |
|
genome-wide haplotype association mapping (ham) |
6 |
|
genotype |
6 |
|
immunohistochemistry |
6 |
|
in situ hybridization |
6 |
|
japan |
6 |
|
messenger rna |
6 |
|
mice, inbred strains |
6 |
|
mineral metabolism |
6 |
|
osteoblasts - metabolism |
6 |
|
osteoporosis - genetics - metabolism |
6 |
|
pedigree |
6 |
|
proteins - genetics |
6 |
|
proto-oncogene proteins - genetics - metabolism |
6 |
|
reverse transcriptase polymerase chain reaction |
6 |
|
southern chinese women |
6 |
|
stroke |
6 |
|
therapeutics |
6 |
|
transcription factor gata 2 |
6 |
|
vitamin d |
6 |
|
adverse drug reaction |
5 |
|
adverse events |
5 |
|
agranulocytosis |
5 |
|
association study |
5 |
|
avascular necrosis |
5 |
|
bone density - genetics - physiology |
5 |
|
bone turnover markers |
5 |
|
chromosomes, human, pair 1 |
5 |
|
chromosomes, human, pair 11 |
5 |
|
chromosomes, human, pair 14 |
5 |
|
clinical outcomes |
5 |
|
depression |
5 |
|
femur - metabolism |
5 |
|
follow-up |
5 |
|
fractures, bone - epidemiology - genetics |
5 |
|
glucocorticoids |
5 |
|
hospitals |
5 |
|
latent tgf-beta binding proteins - genetics |
5 |
|
lean mass |
5 |
|
leiomyoma with bizarre nuclei |
5 |
|
leiomyosarcoma |
5 |
|
linkage |
5 |
|
linkage disequilibrium |
5 |
|
lod score |
5 |
|
lumbosacral region - anatomy & histology |
5 |
|
medical sciences |
5 |
|
pelvic bones - metabolism |
5 |
|
phosphohistone-h3 |
5 |
|
quantitative trait loci |
5 |
|
research design |
5 |
|
sarcopenia |
5 |
|
sars |
5 |
|
smooth muscle tumour of uncertain malignant potential |
5 |
|
spine - anatomy & histology - physiology |
5 |
|
systematic review |
5 |
|
uterus |
5 |
|
vertebral fracture |
5 |
|
25-hydroxyvitamin d |
4 |
|
asthma |
4 |
|
beta-trace protein |
4 |
|
bia |
4 |
|
binding sites - genetics |
4 |
|
biomarker |
4 |
|
biomedicine |
4 |
|
blood lead level |
4 |
|
bone density - physiology |
4 |
|
bone health |
4 |
|
bronchiectasis |
4 |
|
caffeine |
4 |
|
cdx1 |
4 |
|
cell adhesion molecules - genetics - metabolism |
4 |
|
child development |
4 |
|
chinese postmenopausal women |
4 |
|
coffee |
4 |
|
coronary artery disease |
4 |
|
ct |
4 |
|
cva |
4 |
|
diabetes mellitus |
4 |
|
dxa |
4 |
|
falls |
4 |
|
familial hypercholesterolemia |
4 |
|
femur neck - physiology |
4 |
|
ferritin |
4 |
|
fracture prevention |
4 |
|
gene frequency |
4 |
|
genetic predisposition to disease |
4 |
|
gestation |
4 |
|
hip - physiology |
4 |
|
hkos score |
4 |
|
homeodomain proteins - metabolism |
4 |
|
human genetics |
4 |
|
inflammation |
4 |
|
internal medicine |
4 |
|
iron |
4 |
|
ldl-c |
4 |
|
ldl-receptor related proteins - genetics |
4 |
|
low density lipoprotein receptor-related protein-5 |
4 |
|
lrp5 |
4 |
|
lumbar vertebrae - physiology |
4 |
|
metabolic diseases |
4 |
|
metabolic syndrome |
4 |
|
metabolomics |
4 |
|
metabolomics study |
4 |
|
molecular medicine |
4 |
|
nafld |
4 |
|
nafld liver fat score |
4 |
|
nhanes |
4 |
|
nhanes iii |
4 |
|
offspring |
4 |
|
osteoporotic fractures - genetics - physiopathology |
4 |
|
parathyroid hormone |
4 |
|
periostin |
4 |
|
pre-diabetes |
4 |
|
pregnancy |
4 |
|
promoter regions, genetic - genetics |
4 |
|
protein binding - genetics |
4 |
|
replication |
4 |
|
sequence analysis, dna |
4 |
|
serum calcium |
4 |
|
serum metabolites |
4 |
|
snp |
4 |
|
spinal fractures - genetics - physiopathology |
4 |
|
statins |
4 |
|
threshold level |
4 |
|
thyroid |
4 |
|
transferrin saturation |
4 |
|
vitamin d binding protein |
4 |
|
vitamin d insufficiency |
4 |
|
adhd |
3 |
|
akap11 |
3 |
|
alleles |
3 |
|
allergic rhinitis |
3 |
|
alox15 |
3 |
|
antifibrinolytic agents - adverse effects |
3 |
|
apob gene |
3 |
|
arachidonate 15-lipoxygenase - genetics |
3 |
|
area under curve |
3 |
|
asian |
3 |
|
asian continental ancestry group |
3 |
|
beta-2 microglobulin |
3 |
|
bioimpedance |
3 |
|
blood pressure |
3 |
|
body composition |
3 |
|
body weight |
3 |
|
bone and bones - pathology |
3 |
|
bone loss |
3 |
|
bone mass density |
3 |
|
calcium & bone |
3 |
|
calcium blood level |
3 |
|
cardiovascular diseases |
3 |
|
cascade screening |
3 |
|
children |
3 |
|
cholesterol |
3 |
|
chromosomes, human, pair 17 |
3 |
|
chromosomes, human, pair 17 - genetics |
3 |
|
chronic disease |
3 |
|
chronic kidney disease |
3 |
|
clinical pharmacology |
3 |
|
cross-sectional study |
3 |
|
diabetes & endocrinology |
3 |
|
diabetic nephropathy |
3 |
|
different intervention thresholds |
3 |
|
drug safety |
3 |
|
dual-energy x-ray absorptiometry |
3 |
|
dyslipidemia |
3 |
|
early infarct |
3 |
|
electric impedance |
3 |
|
endocrinology |
3 |
|
estrogens - deficiency |
3 |
|
follicle stimulating hormone (fsh) |
3 |
|
follicle stimulating hormone - blood |
3 |
|
follow-up studies |
3 |
|
fracture incidence |
3 |
|
frax with nhanes t-score |
3 |
|
gait |
3 |
|
gait speed |
3 |
|
gene-environment interaction |
3 |
|
genetic epidemiology |
3 |
|
genetic spectrum |
3 |
|
genetic test |
3 |
|
handgrip strength |
3 |
|
haplotype |
3 |
|
heritability |
3 |
|
hypertension |
3 |
|
icd-9 |
3 |
|
individualized medicine |
3 |
|
infarction - chemically induced - pathology |
3 |
|
interstitial lung disease |
3 |
|
kidney |
3 |
|
ldl |
3 |
|
ldlr gene |
3 |
|
leiomyoma |
3 |
|
leiomyoma - complications - drug therapy - pathology |
3 |
|
lipid metabolism |
3 |
|
low-density lipoprotein |
3 |
|
mc3t3-e1 |
3 |
|
menopausal transition |
3 |
|
menopause |
3 |
|
menopause - physiology |
3 |
|
menorrhagia |
3 |
|
menorrhagia - drug therapy - etiology - pathology |
3 |
|
mineralization |
3 |
|
multimorbidity |
3 |
|
necrosis |
3 |
|
organ size |
3 |
|
osteogenesis |
3 |
|
osteoporosis - diagnosis - physiopathology |
3 |
|
osteoprotegerin |
3 |
|
osteoprotegerin - blood - genetics |
3 |
|
paralyses, familial periodic - ethnology - etiology - genetics |
3 |
|
parkinson's disease |
3 |
|
peripheral arterial disease |
3 |
|
pharmacogenomics |
3 |
|
pharmacotherapy |
3 |
|
phytosterol |
3 |
|
plant sterol |
3 |
|
polymorphism, single nucleotide - physiology |
3 |
|
positive predictive value |
3 |
|
postmenopause |
3 |
|
postmenopause - physiology |
3 |
|
potassium channels, inwardly rectifying - genetics |
3 |
|
premenopause |
3 |
|
psychopharmacology |
3 |
|
psychotropic drugs |
3 |
|
public health |
3 |
|
quantitative trait loci - genetics - physiology |
3 |
|
rankl |
3 |
|
regression analysis |
3 |
|
roc curve |
3 |
|
smooth muscle tumor |
3 |
|
statin therapy |
3 |
|
thrombosis - chemically induced - pathology |
3 |
|
thyrotoxicosis - complications - ethnology - genetics |
3 |
|
tranexamic acid |
3 |
|
tranexamic acid - adverse effects |
3 |
|
ubiquitin-protein ligases |
3 |
|
uterine neoplasms - complications - drug therapy - pathology |
3 |
|
variance component |
3 |
|
vitamin k |
3 |
|
warfarin |
3 |
|
25‐hydroxyvitamin d |
2 |
|
absorptiometry, photon - methods |
2 |
|
age factors |
2 |
|
all-cause mortality |
2 |
|
allergic sensitization |
2 |
|
asian continental ancestry group - psychology - statistics & numerical data |
2 |
|
atherosclerosis |
2 |
|
body build |
2 |
|
body fat |
2 |
|
body mass |
2 |
|
body weight loss |
2 |
|
bogalusa |
2 |
|
bogalusa heart study |
2 |
|
bone densitometry. |
2 |
|
cardiovascular disease prevention |
2 |
|
cardiovascular outcome |
2 |
|
carotid artery |
2 |
|
case control study |
2 |
|
causation |
2 |
|
diabetic nephropathies |
2 |
|
discriminative value |
2 |
|
doubling of creatinine |
2 |
|
editorials |
2 |
|
ethnic-specific clinic risk factors |
2 |
|
femur neck - physiopathology |
2 |
|
fracture prediction |
2 |
|
frax |
2 |
|
galectin-3 |
2 |
|
genetic linkage |
2 |
|
genomewide association studies |
2 |
|
genomics |
2 |
|
glomerular filtration rate |
2 |
|
high-throughput nucleotide sequencing |
2 |
|
hip fractures - epidemiology - etiology - physiopathology |
2 |
|
hong kong - epidemiology |
2 |
|
incident macroalbuminuria |
2 |
|
instrumental variables analysis |
2 |
|
life style - ethnology |
2 |
|
liver fat score |
2 |
|
lumbar vertebrae - physiopathology |
2 |
|
non-alcoholic fatty liver disease score |
2 |
|
osteoporosis - epidemiology - genetics - therapy |
2 |
|
osteoporosis - genetic aspects. |
2 |
|
osteoporosis, postmenopausal - complications - epidemiology - physiopathology |
2 |
|
osteoporotic fracture |
2 |
|
osteoporotic fractures - epidemiology - etiology - physiopathology |
2 |
|
prescription medications |
2 |
|
progression of renal failure |
2 |
|
renal fibrosis |
2 |
|
risk assessment - methods |
2 |
|
transcription factors. |
2 |
|
type 2 diabetes |
2 |
|
多態性單核苷酸(polymorphism, single nucleotide) |
2 |
|
連鎖圖(mapping, linkage) |
2 |
|
遺傳標記(genetic markers) |
2 |
|
骨質疏松(osteoporosis) |
2 |
|
骨質疏松性骨折(osteoporotic fractures) |
2 |
|
accident prevention |
1 |
|
alkaline phosphatase - genetics |
1 |
|
alpl |
1 |
|
ankh |
1 |
|
block clustering |
1 |
|
bone geometry |
1 |
|
calcification, physiologic - genetics |
1 |
|
canada |
1 |
|
chromosomes, human, pair 4 |
1 |
|
clinical effectiveness |
1 |
|
cognitive performance |
1 |
|
computational biology |
1 |
|
dietary supplements |
1 |
|
dual energy x ray absorptiometry |
1 |
|
enpp1 |
1 |
|
europe |
1 |
|
european continental ancestry group - genetics |
1 |
|
femoral geometry |
1 |
|
fracture rates |
1 |
|
fracture risk assessment metabolomics |
1 |
|
gene regulatory networks - genetics |
1 |
|
genetic pleiotropy - genetics |
1 |
|
genome, human - genetics |
1 |
|
genome-wide association |
1 |
|
heterozygote |
1 |
|
hip - anatomy & histology |
1 |
|
hip fracture |
1 |
|
hip fractures |
1 |
|
homeodomain proteins - genetics |
1 |
|
homozygote |
1 |
|
immunoassay |
1 |
|
inflammatory markers |
1 |
|
international cooperation |
1 |
|
muscle mass |
1 |
|
osteoporosis - genetics |
1 |
|
osteoporosis - genetics - physiopathology |
1 |
|
osteoporotic fractures - genetics |
1 |
|
phenomics |
1 |
|
phenotype |
1 |
|
phosphate transport proteins - genetics |
1 |
|
phosphoric diester hydrolases - genetics |
1 |
|
polymorphism, single nucleotide - genetics |
1 |
|
principal component analysis |
1 |
|
pyrophosphatases - genetics |
1 |
|
quantitative trait, heritable |
1 |
|
quantitative ultrasound |
1 |
|
sars-cov-2 infection |
1 |
|
seasons |
1 |
|
single nucleotide polymorphisms |
1 |
|
united states |
1 |
|
vitamin d - analogs & derivatives - blood - genetics |
1 |
|
vitamin d deficiency - blood - genetics - prevention & control |
1 |
